Your browser doesn't support javascript.
loading
A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.
Xu, Zicheng; Li, Xiao; Qi, Feng; Hu, Xin; Zheng, Yuxiao; Cai, Hongzhou; Xu, Ting; Yu, Bin; Zou, Qing.
Afiliación
  • Xu Z; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Li X; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Qi F; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Hu X; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Zheng Y; Department of Urology, First Clinical Medical College of Nanjing Medical University, Nanjing 210029, China.
  • Cai H; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Xu T; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Yu B; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Zou Q; Department of Urologic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Transl Androl Urol ; 8(4): 339-345, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31555557

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Androl Urol Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China